Type 2 diabetes screening in at-risk patients may not decrease mortality risk

Population-based screening for type 2 diabetes in at-risk patients did not decrease the risk of diabetes-related mortality within 10 years, a recently published study found. Additionally, neither cardiovascular nor all-cause mortality risk was reduced.

Key Point: Population-based diabetes screening did not decrease diabetes-related or all-cause mortality within 10 years in a recent study of at-risk patients. Patients with detectable disease indicated through clinical signs and symptoms should still receive early diagnosis and treatment, and high-risk patients should be counseled about prevention.

Type 2 diabetes is on the rise globally, including in India. This public health challenge has given rise to questions about whether...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Diabetes, Primary Care and tagged , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.